Taro Announces Appointment of Interim CEO

Taro Announces Appointment of Interim CEO


As previously announced, the Interim CEO will serve in this role during the period from Mr. Kal Sundaram's departure at the end of this year until the arrival in April 2017 of Mr. Uday Baldota, Taro's recently appointed CEO. Mr. Gandhi currently serves as the CEO of the Sun Pharmaceutical Industries Ltd. North America operations, a position he succeeded from Mr. Sundaram.



from Biotech News